Revelation Biosciences REVB Income Statement (2020-2026)

NASDAQ REVB
$1.09 -0.02 (-1.80%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating items
Research & Development (Quarter)
1.16M1.53M2.67M3.68M0.98M0.38M0.34M0.53M0.91M1.65M1.06M0.09M0.11M0.02M0.10M0.02M0.02M0.02M0.96M1.92M
Selling, General & Administrative (Quarter)
1.28M1.51M1.19M2.91M0.88M0.82M0.88M1.09M1.02M1.13M1.27M1.18M1.13M0.97M1.15M1.24M1.14M1.02M1.61M1.74M
Other Operating Expenses (Quarter)
0.63M1.28M0.81M0.51M0.84M1.30M0.90M
Operating Expenses (Quarter)
2.44M3.04M3.86M6.59M1.86M1.20M1.22M1.62M1.93M2.78M2.33M1.90M2.52M1.80M1.75M2.09M2.46M1.94M2.57M
Operating Income (Quarter)
-2.44M-3.04M-3.86M-6.59M-1.86M-1.20M-1.22M-1.62M-1.93M-2.78M-2.33M-1.90M-2.52M-1.80M-1.75M-2.09M-2.46M-1.94M-2.57M
EBIT (Quarter)
-2.44M-3.04M-3.86M-6.59M-1.86M-1.20M-1.22M-1.62M-1.93M-2.78M-2.33M-1.90M-2.52M-1.80M-1.75M-2.09M-2.46M-1.94M-2.57M
Non-operating items
Interest & Investment Income (Quarter)
0.00M0.00M-0.01M
Other Non Operating Income (Quarter)
-0.03M-557.00-0.00M-0.03M0.03M0.03M0.01M0.03M0.06M0.06M0.05M-0.85M-5.87M-0.45M0.03M0.04M0.02M0.04M0.06M
Non Operating Income (Quarter)
-0.03M-557.00-0.00M-0.03M0.03M0.03M0.01M7.78M0.48M0.15M0.12M-0.78M-5.87M-0.44M0.03M0.04M0.02M0.04M0.06M
Net income details
EBT (Quarter)
-2.44M-3.04M-4.21M-6.64M-1.89M-1.22M-1.59M-1.71M-1.99M-2.81M-12.83M-1.94M-2.55M-1.81M-2.23M-2.09M-2.46M-1.94M-2.71M
Profit After Tax (Quarter)
-2.47M-3.04M-3.86M-6.62M-1.83M-1.17M-1.21M6.16M-1.45M-2.63M-2.20M-2.68M-8.39M-2.24M-1.73M-2.05M-2.44M-1.91M-2.50M
Income from Continuing Operations (Quarter)
-2.44M-3.04M-4.21M-6.64M-1.89M-1.22M-1.59M-1.71M-1.99M-2.81M-12.83M-1.94M-2.55M-1.81M-2.23M-2.09M-2.46M-1.94M-2.71M
Consolidated Net Income (Quarter)
-2.44M-3.04M-4.21M-6.64M-1.89M-1.22M-1.59M-1.71M-1.99M-2.81M-12.83M-1.94M-2.55M-1.81M-2.23M-2.09M-2.46M-1.94M-2.71M
Income towards Parent Company (Quarter)
-2.44M-0.76M-4.21M-6.64M-1.89M-1.22M-1.59M-1.71M-1.99M-2.81M-12.83M-1.94M-2.55M-1.81M-2.23M-2.09M-2.46M-1.94M-2.71M
Preferred Dividend Payments (Quarter)
3.18M2.77M
Net Income towards Common Stockholders (Quarter)
0.00M0.00M0.00M-6.64M-1.89M-1.22M-1.59M-1.71M-1.99M-2.81M-12.83M-1.94M-8.39M-2.24M-1.73M-2.09M-5.63M-4.68M-2.51M
Additional items
EPS (Basic) (Quarter)
203.67205.89130.22-0.09M-0.03M-0.01M-0.02M-0.00M-0.00M-0.00M-0.01M-342.66-985.07-160.59-120.75-25.88-28.04-7.07-4.04
EPS (Diluted) (Quarter)
59.1359.7723.92-0.09M-0.03M-0.01M-0.02M-0.00M-0.00M-0.00M-0.01M-342.66-985.07-160.59-120.75-25.88-28.04-7.07-4.04
Shares Outstanding (Quarter)
9.009.009.0070.0075.00104.0094.00384.000.00M0.00M0.00M0.01M0.01M0.01M0.01M0.08M0.20M0.66M0.62M
Shares Outstanding (Diluted) (Quarter)
31.0031.0049.0072.0075.00104.0094.00544.000.00M0.00M0.00M0.01M0.01M0.01M0.01M0.08M0.20M0.66M0.62M
Shares Outstanding (Entity) (Quarter)
9.009.009.0075.0075.00117.0094.00384.000.00M0.00M0.00M0.01M0.01M0.01M0.01M0.08M0.20M0.66M0.62M
EBITDA (Quarter)
-2.44M-3.04M-3.86M-6.59M-1.86M-1.20M-1.22M-1.62M-1.93M-2.78M-2.33M-1.90M-2.52M-1.80M-1.75M-2.09M-2.46M-1.94M-2.57M
Interest Expenses (Quarter)
0.35M0.05M0.03M0.02M0.37M0.09M0.06M0.03M10.50M0.04M0.03M0.01M0.48M0.14M